SHIFT Newsroom · GLOBAL
Graves’ disease during tirzepatide treatment: a case report
A case report describes unilateral Graves’ disease developing in a woman receiving tirzepatide.
A case report describes unilateral Graves’ disease developing in a woman receiving tirzepatide. The authors explicitly state that a causal relationship cannot be established. The sequence of events does not make this a confirmed side effect or establish its frequency. The report highlights the need to assess symptoms rather than automatically attribute them to an existing medicine.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.